ClassID:

95321

C07D451/04 - CPC Classification

Classification description:

Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system

Sub-classes:
Recent Application in this class:
#1
20250296935
2025-09-25

Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase

#2
20250270188
2025-08-28

NLRP3 INFLAMMASOME INHIBITORS

#3
20250161281
2025-05-22

EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF

#4
20240293362
2024-09-05

Soluble Epoxide Hydrolase Inhibitors and Use Thereof

#5
20240216357
2024-07-04

POLYCYCLIC COMPOUND AND APPLICATION THEREOF

#6
20240174611
2024-05-30

SUBSTITUTED CYCLIC MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME

#7
20240158389
2024-05-16

Pyrimidine compound as JAK kinase inhibitor

#8
20240148722
2024-05-09

SMALL MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF ALS AND RELATED DISORDERS

#9
20230331718
2023-10-19

COMPOSITIONS FOR MODULATING SPLICING

#10
20230295122
2023-09-21

1H-BENZO[D]IMIDAZOLE DERIVATIVES AS TLR9 INHIBITORS FOR THE TREATMENT OF FIBROSIS

#11
20230250104
2023-08-10

Diamine derivatives as inhibitors of leukotriene Ahydrolase

#12
20230219956
2023-07-13

QUINAZOLINE COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF

#13
20230165848
2023-06-01

CHEMICAL COMPOUNDS

#14
20230108114
2023-04-06

PRMT5 INHIBITORS

#15
20230101819
2023-03-30

SMYD Inhibitors

#16
20230072397
2023-03-09

Antimicrobial Compounds and Methods

#17
20230071039
2023-03-09

Serotonin 5-HT2B inhibitory compounds

#18
20230059865
2023-02-23

Methods and compositions for modulating splicing

#19
20230043863
2023-02-09

HETEROAROMATIC DERIVATIVES FOR USE AS REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF

#20
20220403383
2022-12-22

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

#21
20220396573
2022-12-15

Pyrimidine compound as JAK kinase inhibitor

#22
20220251067
2022-08-11

NLRP3 inflammasome inhibitors

#23
20220024920
2022-01-27

ADO-resistant cysteamine analogs and uses thereof

#24
20210387969
2021-12-16

Bicyclic aza compounds as muscarinic Mand/or Mreceptor agonists

#25
20210369710
2021-12-02

MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN

#26
20210292316
2021-09-23

Compounds for the treatment of cancer

#27
20210230176
2021-07-29

Hepatitis B antiviral agents

#28
20210214349
2021-07-15

Pyrimidine compound as JAK kinase inhibitor

#29
20210198252
2021-07-01

SMYD INHIBITORS

#30
20210009519
2021-01-14

HISTONE DEACETYLASE INHIBITORS

#31
20200392140
2020-12-17

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

#32
20200369660
2020-11-26

Pyrimidine compound as JAK kinase inhibitor

#33
20200361899
2020-11-19

NLRP3 inflammasome inhibitors

#34
20200361898
2020-11-19

NLRP3 inflammasome inhibitors

#35
20200308181
2020-10-01

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#36
20200297710
2020-09-24

Chemical compounds

#37
20200277289
2020-09-03

Methods and compositions for modulating splicing

#38
20200247799
2020-08-06

Methods and compositions for modulating splicing

#39
20200224199
2020-07-16

Methods and compositions for modulating splicing

#40
20200199143
2020-06-25

Hepatitis B antiviral agents

#41
20200140430
2020-05-07

Pyrimidine compound as JAK kinase inhibitor

#42
20200046709
2020-02-13

Pyrimidine compounds as JAK kinase inhibitors

#43
20190382342
2019-12-19

Histone deacetylase inhibitors

#44
20190330233
2019-10-31

Benzopiperazine compositions as BET bromodomain inhibitors

#45
20190322676
2019-10-24

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

#46
20190322660
2019-10-24

SMYD INHIBITORS

#47
20190292167
2019-09-26

HETEROAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#48
20190284226
2019-09-19

Thionyl tetrafluoride modified compounds and uses

#49
20190241555
2019-08-08

Pyrimidine compound as JAK kinase inhibitor

#50
20190194183
2019-06-27

Triazolopyridines

#51
20190119263
2019-04-25

6-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereof

#52
20190112311
2019-04-18

Therapeutic compound for pain and synthesis thereof

#53
20190084994
2019-03-21

Hepatitis B antiviral agents

#54
20180370915
2018-12-27

Histone deacetylase inhibitors

#55
20180354960
2018-12-13

Biphenyl compound or salt thereof

#56
20180354939
2018-12-13

SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS

#57
20180354902
2018-12-13

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#58
20180327406
2018-11-15

Therapeutic compounds for pain and synthesis thereof

#59
20180327405
2018-11-15

Therapeutic compounds for pain and synthesis thereof

#60
20180319772
2018-11-08

Inhibitors of cyclin-dependent kinase 7 (CDK7)

#61
20180312524
2018-11-01

Benzopiperazine compositions as BET bromodomain inhibitors

#62
20180312503
2018-11-01

Nitrogen-containing aromatic heterocyclic compound

#63
20180303836
2018-10-25

Pyrimidine compounds as JAK kinase inhibitors

#64
20180291024
2018-10-11

Therapeutic compounds for pain and synthesis thereof

#65
20180273476
2018-09-27

AMINE DERIVATIVES AS POTASSIUM CHANNEL BLOCKERS

#66
20180258085
2018-09-13

Bicyclic aza compounds as muscarinic M1 receptor antagonists

#67
20180244653
2018-08-30

Selective alpha-7 nicotinic receptor agonists and methods for making and using them

#68
20180230159
2018-08-16

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

#69
20180169094
2018-06-21

Substituted pyrazoles as IRAK inhibitors

#70
20180037566
2018-02-08

Therapeutic compounds and uses thereof

#71
20180030045
2018-02-01

Selectively substituted quinoline compounds

#72
20180002327
2018-01-04

Heteroaryl compounds as IRAK inhibitors and uses thereof

#73
20170362217
2017-12-21

Substituted piperidine compounds

#74
20170355695
2017-12-14

Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer

#75
20170342074
2017-11-30

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

#76
20170334901
2017-11-23

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

#77
20170327503
2017-11-16

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

#78
20170253609
2017-09-07

Hepatitis B antiviral agents

#79
20170247369
2017-08-31

Bicyclic AZA compounds as muscarinic M1 receptor antagonists

#80
20170197983
2017-07-13

Heterocyclic compounds having cholesterol 24-hydroxylase activity

#81
20170183355
2017-06-29

Inhibitors of cyclin-dependent kinase 7 (CDK7)

#82
20170088519
2017-03-30

Amine derivatives as potassium channel blockers

#83
20170044187
2017-02-16

1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof

#84
20170008844
2017-01-12

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#85
20170002004
2017-01-05

ADO-resistant cysteamine analogs and uses thereof

#86
20160333021
2016-11-17

Metallo-beta-lactamase inhibitors

#87
20160326161
2016-11-10

SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS

#88
20160272617
2016-09-22

SUBSTITUTED PHENYLALANINE DERIVATIVES

#89
20160264552
2016-09-15

HETEROMAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLFERATIVE DISEASES

#90
20160251346
2016-09-01

3,3-disubstituted-(8-aza-bicyclo[3.2.1]OCT-8-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanones as inhibitors of 11 (β)-HSD1

#91
20160207905
2016-07-21

Substituted pyrimidine compounds, compositions and medicinal applications thereof

#92
20160159785
2016-06-09

Substituted-quinoxaline-type piperidine compounds and the uses thereof

#93
20160145252
2016-05-26

Heteroaryl compounds as IRAK inhibitors and uses thereof

#94
20160128996
2016-05-12

Bicyclic aza compounds as muscarinic M1 receptor agonists

#95
20150315209
2015-11-05

Heterocyclic compounds having cholesterol 24-hydroxylase activity

#96
20150307475
2015-10-29

Autotaxin inhibitors

#97
20150299184
2015-10-22

Amine Derivatives as Potassium Channel Blockers

#98
20150291580
2015-10-15

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

#99
20150284408
2015-10-08

Inhibitors of DNA gyrase for the treatment of bacterial infections

#100
20150284331
2015-10-08

Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereof

#101
20150148344
2015-05-28

Quinoline derivatives as bromodomain inhibitors

#102
20150141643
2015-05-21

Substituted-quinoxaline-type piperidine compounds and the uses thereof

#103
20150080382
2015-03-19

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#104
20150072972
2015-03-12

PHTHALAZINE DERIVATIVES AS PARP INHIBITORS

#105
20150057282
2015-02-26

Oxazole tyrosine kinase inhibitors

#106
20150025054
2015-01-22

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#107
20140336198
2014-11-13

Amine derivatives as potassium channel blockers

#108
20140323490
2014-10-30

Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

#109
20140275074
2014-09-18

Heterocyclic derivative having PGD2 receptor antagonist activity

#110
20140275057
2014-09-18

Compounds and compositions for the inhibition of NAMPT

#111
20140256769
2014-09-11

Crystalline form of a quinolinone-carboxamide compound

#112
20140221420
2014-08-07

CCR5 antagonists for treating HIV

#113
20140221364
2014-08-07

Tetrahydroquinoline analogues as muscarinic agonists

#114
20140213585
2014-07-31

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

#115
20140187544
2014-07-03

Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators

#116
20140171404
2014-06-19

Autotaxin inhibitors

#117
20140163063
2014-06-12

Quinolinone-carboxamide compounds as 5-HTreceptor agonists

#118
20140142084
2014-05-22

Nitrogen-containing aromatic heterocyclic compound

#119
20140094450
2014-04-03

Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators

#120
20140093518
2014-04-03

Chemically Programmed Vaccination

#121
20140057942
2014-02-27

Rock inhibitors

#122
20140030191
2014-01-30

1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof

#123
20130310379
2013-11-21

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

#124
20130281485
2013-10-24

Bridged bicyclic RHO kinase inhibitor compounds, compositions and use

#125
20130281476
2013-10-24

Modulators of Muscarinic Receptors

#126
20130217715
2013-08-22

Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents

#127
20130211091
2013-08-15

Crystalline forms of maraviroc phosphate and process for maraviroc amorphous form

#128
20130190351
2013-07-25

Bicyclic amides for enhancing glutamatergic synaptic responses

#129
20130157981
2013-06-20

Substituted pyrazines and their use in the treatment of disease

#130
20130123268
2013-05-16

3,3-disubstituted-(8-aza-bicyclo[3.2.1]oct-8-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanones as inhibitors of 11 (β)-HSD1

#131
20130123243
2013-05-16

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

#132
20130079514
2013-03-28

Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells

#133
20130018041
2013-01-17

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

#134
20120302541
2012-11-29

4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators

#135
20120295877
2012-11-22

Therapeutic compounds

#136
20120283243
2012-11-08

Spiroindoline modulators of muscarinic receptors

#137
20120264779
2012-10-18

Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

#138
20120264740
2012-10-18

Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

#139
20120225884
2012-09-06

Bridged piperidine derivatives

#140
20120028970
2012-02-02

HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE

#141
20110311516
2011-12-22

Chemically programmed vaccination

#142
20110306597
2011-12-15

Nicotinamide Derivatives

#143
20110294749
2011-12-01

DIAMINOPYRIMIDINECARBOXAMIDE DERIVATIVE

#144
20110263639
2011-10-27

Aryl-substituted bridged or fused diamines as modulators of leukotriene Ahydrolase

#145
20110257153
2011-10-20

Aryl-substituted bridged or fused diamines as modulators of leukotriene A ydrolase

#146
20110251192
2011-10-13

Amide compounds, their pharmaceutical compositions, their preparation method and their uses

#147
20110178075
2011-07-21

INDOLES, 1H-INDAZOLES, 1,2-BENZISOXAZOLES, 1,2-BENZOISOTHIAZOLES, AND PREPARATION AND USES THEREOF

#148
20110178055
2011-07-21

Dual NK1/NK3 receptor antagonists

#149
20110172227
2011-07-14

Alkyl 3-((2-amidoethyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate analogs as selective M1 agonists and methods of making and using same

#150
20110166169
2011-07-07

HSP90 inhibitory carbazole derivatives, compositions containing same and use thereof

#151
20110160235
2011-06-30

TRIAZOLYL TROPANE DERIVATIVES

#152
20110144151
2011-06-16

Process, salts, composition and use

#153
20110144150
2011-06-16

Bridged bicyclic RHO kinase inhibitor compounds, composition and use

#154
20110124693
2011-05-26

5-PHENYL-4-METHYL-THIAZOL-2-YL-AMINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3 KINASE ENZYMES (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES

#155
20110124676
2011-05-26

Biaryl substituted azabicyclic alkane derivatives

#156
20110124624
2011-05-26

5-PHENYL-4-METHYL-THIAZOL-2-YL-AMINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3 KINASE ENZYMES (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES

#157
20110123555
2011-05-26

PREPARATION AND UTILITY OF CCR5 INHIBITORS

#158
20110118305
2011-05-19

COMPOUNDS

#159
20110112139
2011-05-12

NOVEL 8-AZA-BICYCLO[3.2.1]OCTANE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS

#160
20110105563
2011-05-05

IL-8 RECEPTOR ANTAGONISTS

#161
20110098274
2011-04-28

Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

#162
20110065684
2011-03-17

Phthalazine derivatives as PARP inhibitors

#163
20110059937
2011-03-10

IL-8 RECEPTOR ANTAGONISTS

#164
20110059929
2011-03-10

Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11β-hydroxysteroid dehydrogenase type-1

#165
20110053912
2011-03-03

Pyrimidine compound

#166
20110039822
2011-02-17

HETEROCYCLIC JANUS KINASE 3 INHIBITORS

#167
20110003835
2011-01-06

Methods for the treatment of respiratory depression

#168
20100331348
2010-12-30

TROPANE DERIVATIVES USEFUL AS PESTICIDES

#169
20100331310
2010-12-30

BICYCLOAMINE DERIVATIVES

#170
20100324049
2010-12-23

DIARYL KETIMINE DERIVATIVE HAVING ANTAGONISM AGAINST MELANIN-CONCENTRATING HORMONE RECEPTOR

#171
20100311979
2010-12-09

Quinolinone-carboxamide compounds as 5-HTreceptor agonists

#172
20100311720
2010-12-09

Spiroindoline modulators of muscarinic receptors

#173
20100305066
2010-12-02

Fused thiophene derivatives as kinase inhibitors

#174
20100298301
2010-11-25

Oxazole tyrosine kinase inhibitors

#175
20100297035
2010-11-25

Thiazole Amides, Imidazole Amides and Related Analogues

#176
20100292223
2010-11-18

Indazole-carboxamide compounds

#177
20100286177
2010-11-11

Bicyclic amides for enhancing glutamatergic synaptic responses

#178
20100285519
2010-11-11

Quinolinone-carboxamide compounds as 5-HTreceptor agonists

#179
20100261716
2010-10-14

Indazole-carboxamide compounds as 5-HTreceptor agonists

#180
20100256357
2010-10-07

HETEROCYCLES USEFUL AS INHIBITORS OF CARBONIC ANHYDRASE

#181
20100234392
2010-09-16

4-sulfonylpiperidine derivatives

#182
20100216726
2010-08-26

Substituted-quinoxaline-type piperidine compounds and the uses thereof

#183
20100210838
2010-08-19

Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity

#184
20100210630
2010-08-19

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#185
20100197909
2010-08-05

Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position

#186
20100197728
2010-08-05

Crystalline form of a quinolinone-carboxamide compound

#187
20100184987
2010-07-22

Preparation of Retapamulin via its Pleuromutilin-thiol precursor

#188
20100179164
2010-07-15

2,4-pyrimidinediamine compounds for treatment of inflammatory disorders

#189
20100173935
2010-07-08

Muscarinic Receptor Agonists that are Effective in the Treatment of Pain, Alzheimer's Disease and Schizophrenia

#190
20100168416
2010-07-01

Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

#191
20100152167
2010-06-17

Pyrimidine derivatives

#192
20100105915
2010-04-29

CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS

#193
20100105693
2010-04-29

Modulators of Muscarinic Receptors

#194
20100105675
2010-04-29

11 β-HSD1 modulators

#195
20100093709
2010-04-15

TRICYCLIC DELTA OPIOID MODULATORS

#196
20100087364
2010-04-08

TROPINE MODULATORS OF 5-HT3 RECEPTOR

#197
20100048613
2010-02-25

Polymorphic form of granisetron hydrochloride and methods of making the same

#198
20100010007
2010-01-14

PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR CCR5

#199
20090298810
2009-12-03

IL-8 receptor antagonists

#200
20090281072
2009-11-12

Diaminopyrimidinecarboxamide derivative

#201
20090275556
2009-11-05

Aryl sulfonamides useful as inhibitors of chemokine receptor activity

#202
20090270376
2009-10-29

Heterocyclic janus kinase 3 inhibitors

#203
20090270369
2009-10-29

Bicycloamine derivatives

#204
20090258864
2009-10-15

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

#205
20090247568
2009-10-01

Aminopiperidinyl derivatives and uses thereof

#206
20090247515
2009-10-01

11 Beta-HSD1 Modulators

#207
20090239903
2009-09-24

Tetrahydroquinoline analogues as muscarinic agonists

#208
20090239873
2009-09-24

Phenyl-piperazine derivatives as modulators of muscarinic receptors

#209
20090234125
2009-09-17

Amorphous retapamulin and processes for preparation thereof

#210
20090197862
2009-08-06

2-aminopyridine kinase inhibitors

#211
20090192186
2009-07-30

Biaryl substituted azabicyclic alkane derivatives

#212
20090187021
2009-07-23

Indane compounds as CCR5 antagonists

#213
20090149655
2009-06-11

Process for the preparation of Retapamulin and its intermediates

#214
20090137806
2009-05-28

Dual NK1/NK3 receptor antagonists

#215
20090131470
2009-05-21

PYRAZOLE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISORDERS

#216
20090130090
2009-05-21

N-amide Derivatives of 8-Azabicyclo[3.2.1]OCT-3-YL AS CCR1 Antagonists

#217
20090124636
2009-05-14

CHEMICAL COMPOUNDS

#218
20090118326
2009-05-07

Nicotinic acetylcholine receptor modulators

#219
20090118232
2009-05-07

Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof

#220
20090111794
2009-04-30

Aryl-substituted bridged or fused diamines as modulators of leukotriene Ahydrolase

#221
20090105248
2009-04-23

3-monosubstituted tropane derivatives as nociceptin receptor ligands

#222
20090093451
2009-04-09

IL-8 Receptor Antagonists

#223
20090076071
2009-03-19

DEUTERIUM-ENRICHED RETAPAMULIN

#224
20090062331
2009-03-05

DEUTERIUM-ENRICHED MARAVIROC

#225
20090053172
2009-02-26

HETEROCYCLIC COMPOUNDS AS CCR5 ANTAGONISTS

#226
20090042871
2009-02-12

Tricyclic δ-opioid modulators

#227
20090036483
2009-02-05

Quinolinone compounds as 5-HTreceptor agonists

#228
20090023710
2009-01-22

Heterocyclic compounds as inhibitors of 17beta-HSD3

#229
20080312212
2008-12-18

Organic Compounds

#230
20080280871
2008-11-13

5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseases

#231
20080279775
2008-11-13

Benztropinamine Analogs as Dopamine Uptake Inhibitors

#232
20080269229
2008-10-30

8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

#233
20080255197
2008-10-16

CXCR4 chemokine receptor binding compounds

#234
20080255187
2008-10-16

5-HTreceptor agonist compounds

#235
20080255114
2008-10-16

2-aminobenzoxazole carboxamides as 5HT3 modulators

#236
20080188455
2008-08-07

Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

#237
20080176895
2008-07-24

Quinolinone-carboxamide compounds as 5-HT, receptor agonists

#238
20080171766
2008-07-17

Novel Method

#239
20080167295
2008-07-10

Quinolinone-carboxamide compounds

#240
20080161342
2008-07-03

Polymorph of mutilin

#241
20080161310
2008-07-03

Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity

#242
20080161264
2008-07-03

Triazolyl tropane derivatives

#243
20080146807
2008-06-19

Indazole-carboxamide compounds as 5-HTreceptor agonists

#244
20080146605
2008-06-19

PREPARATION AND UTILITY OF CCR5 INHIBITORS

#245
20080139568
2008-06-12

Phthalazine derivatives as parp inhibitors

#246
20080132537
2008-06-05

Tropane derivatives useful in therapy

#247
20080132491
2008-06-05

Indazole-carboxamide compounds

#248
20080108609
2008-05-08

Benzoxazole carboxamides for treating CINV and IBS-D

#249
20080090826
2008-04-17

Muscarinic modulators

#250
20080090811
2008-04-17

Carbamate compounds as 5-HTreceptor agonists

#251
20080070923
2008-03-20

Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists

#252
20080045522
2008-02-21

OMEGA-AMINOALKYLAMIDES OF R-2-ARYL-PROPIONIC ACIDS AS INHIBITORS OF THE CHEMOTAXIS OF POLYMORPHONUCLEATE AND MONONUCLEATE CELLS

#253
20080033002
2008-02-07

Modulators of muscarinic receptors

#254
20080009489
2008-01-10

ANDROGEN RECEPTOR MODULATORS AND METHOD OF TREATING DISEASE USING THE SAME

#255
20070293498
2007-12-20

Modulators of melanocortin receptor

#256
20070281970
2007-12-06

Quinolinone-carboxamide compounds as 5-HTreceptor agonists

#257
20070270457
2007-11-22

Quinolinone-carboxamide compounds as 5-HT, receptor agonists

#258
20070265309
2007-11-15

Substituted bis aryl and heteroaryl compounds as selective 5HTantagonists

#259
20070259863
2007-11-08

Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives

#260
20070249672
2007-10-25

IL-8 receptor antagonists

#261
20070249604
2007-10-25

3-monosubstituted tropane derivatives as nociceptin receptor ligands

#262
20070213359
2007-09-13

BICYCLIC-NITROGEN COMPOUNDS AS MODULATORS OF GHRELIN RECEPTOR AND USES THEREOF

#263
20070196270
2007-08-23

Compounds As Ccri Antagonists

#264
20070191364
2007-08-16

AMINOPIPERIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF

#265
20070191361
2007-08-16

Aminotropane derivatives, preparation thereof and therapeutic use thereof

#266
20070191355
2007-08-16

Process for preparing intermediates to 5-HT receptor agonist compounds

#267
20070179158
2007-08-02

2,6-disubstituted piperiddines as modulators

#268
20070167442
2007-07-19

Piperidine derivatives as modulators of chemokine receptor CCR5

#269
20070155726
2007-07-05

Diamine derivatives as inhibitors of leukotriene Ahydrolase

#270
20070149562
2007-06-28

OXOPIPERIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

#271
20070135423
2007-06-14

E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain

#272
20070117796
2007-05-24

Carbamate compounds as 5-HTreceptor agonists

#273
20070099895
2007-05-03

1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof

#274
20070054912
2007-03-08

Modulators of acetylcholine receptors

#275
20070054911
2007-03-08

Muscarinic modulators

#276
20070004679
2007-01-04

Androgen receptor modulators and methods of treating disease using the same

#277
20060276503
2006-12-07

Process salts compositions and use

#278
20060276482
2006-12-07

Benzoimidazolone-carboxamide compounds as 5-HTreceptors agonists

#279
20060264434
2006-11-23

Chemokine receptor binding heterocyclic compounds

#280
20060229336
2006-10-12

CCR5 antagonists as therapeutic agents

#281
20060229332
2006-10-12

Crystalline form of a quinolinone-carboxamide compound

#282
20060199839
2006-09-07

Quinolinone compounds as 5-HTreceptor agonists

#283
20060183901
2006-08-17

Crystalline form of an indazole-carboxamide compound

#284
20060183769
2006-08-17

Benzoxazole carboxamides for treating CINV and IBS-D

#285
20060142331
2006-06-29

8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

#286
20060135764
2006-06-22

Indazole-carboxamide compounds

#287
20060135763
2006-06-22

Tricyclic δ- opioid modulators

#288
20060122171
2006-06-08

Substituted 3-(diarylmethylene)indolin-2-ones and methods of their use

#289
20060122166
2006-06-08

Cyclohexyl compounds as CCR5 antagonists

#290
20060100426
2006-05-11

Quinolinone-carboxamide compounds

#291
20060100236
2006-05-11

5-HTreceptor agonist compounds

#292
20060100211
2006-05-11

Pyrimidine derivatives

#293
20060079505
2006-04-13

Spiroindoline modulators of muscarinic receptors

#294
20060052595
2006-03-09

Heterocyclic compounds as CCR5 antagonists

#295
20060047116
2006-03-02

Indane compounds as CCR5 antagonists

#296
20060040949
2006-02-23

Compounds with anti-bacterial activity

#297
20060019962
2006-01-26

Modulators of muscarinic receptors

#298
20060014780
2006-01-19

Nicotinamide derivatives useful as PDE4 inhibitors

#299
20060014739
2006-01-19

Androgen receptor modulators and method of treating disease using the same

#300
20060004004
2006-01-05

Novel gamma secretase inhibitors